TNX-102 SL Monotherapy Versus Placebo in people with Major Depressive Disorder (MDD)
This study is recruiting in the United States. It is testing TNX-102 SL Monotherapy for depression.
In United StatesThis study is directly about Depression.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the United States. It is testing TNX-102 SL Monotherapy for depression.
In United StatesThis study is directly about Depression.
This study is looking at whether 60Hz Intermittent Light Therapy can help people with Depression, Mdd, or Major Depressive Episode. Participants take part in 60Hz Intermittent Light Therapy and complete follow-up assessments.
Remote / onlineThis study is directly about Depression.
This study is looking at care and outcomes for people with depression. Some participants may receive Sham treatment instead of the study treatment, and direct benefit is not guaranteed.
Remote / onlineThis study is directly about Depression.
This study is looking at care and outcomes for people with Treatment Resistant Depression or depression. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
Remote / onlineThis study is directly about Depression.
This study is recruiting in the United States, in Botswana, in Brazil, .... It focuses on depression.
In United StatesThis study is directly about Depression.
This study is looking at whether Active VeNS Device can help people with depression \(depression or major depression. Participants take part in Active VeNS Device and complete follow-up assessments.
In United StatesThis study is directly about Depression.
This study is comparing SSRI (escitalopram or sertraline) with placebo for people with depression. Participants receive SSRI (escitalopram or sertraline) or placebo and complete study visits and assessments.
In United StatesThis study is directly about Depression.
This study is recruiting in the United States, in Australia, in Canada, .... It is testing Maintenance Effect of NBI-1065845 for depression.
In United StatesThis study is directly about Depression.
This study is recruiting in the United States. It focuses on depression.
In United StatesThis study is directly about Depression.
This study is comparing Psilocybin with Full dose COMP360 with sham aiTBS rTMS for people with Treatment Resistant Depression, Mdd, depression, or Recurrent Depression. Participants receive Psilocybin or Full dose COMP360 with sham aiTBS rTMS and complete study visits and assessments.
In United StatesThis study is directly about Depression.
This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.
In United StatesThis study is directly about Depression.
This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
In United StatesThis study is directly about Depression.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.